Gut Microbiome Diversity in Adults With Inflammatory and Immune-Mediated Skin Diseases (GUMIDIC)
Studio Sulla diversità Del Microbiota Intestinale Umano in Pazienti Con Patologie Infiammatorie Cutanee
This study will examine whether the gut bacteria of adults with inflammatory or immune-mediated skin diseases differ from those of healthy adults. It will include people with atopic dermatitis, psoriasis, hidradenitis suppurativa, vitiligo, alopecia areata, acne, pemphigus, or bullous pemphigoid, as well as healthy controls.
Participants will provide a stool sample and complete a short food diary. The study team will analyze the bacteria in the samples and compare the results between the disease groups and healthy controls. Participants with a skin disease will be asked to provide a second stool sample and complete follow-up assessments about six months later; healthy controls will provide one sample. The study will also examine whether changes in gut bacteria are related to skin disease severity, diet, and other collected health information.
Studie Overzicht
Toestand
Toestand
Conditie
Conditie
Studietype
Studietype
Inschrijving (Geschat)
Inschrijving
Contacten en locaties
Studiecontact
Studiecontact
- Naam: Gianluca Nazzaro, MD
- Telefoonnummer: +39 0255035200
- E-mail: gianluca.nazzaro@policlinico.mi.it
Studie Locaties
-
-
-
Milan, Italië, 20122
- Werving
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
-
Contact:
- Gianluca Nazzaro, MD
- Telefoonnummer: +39 0255035200
- E-mail: gianluca.nazzaro@policlinico.mi.it
-
-
Deelname Criteria
Geschiktheidscriteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Adults aged 18 years or older with one of eight specialist-confirmed inflammatory or immune-mediated skin diseases, plus healthy adult controls without those diseases. Participants are recruited through the Dermatology service at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico in Milan, Italy.
Beschrijving
Inclusion Criteria:
- Age 18 years or older.
- Able and willing to provide informed consent.
- For patient groups: specialist-confirmed diagnosis of atopic dermatitis, psoriasis, hidradenitis suppurativa, vitiligo, alopecia areata, acne, pemphigus, or bullous pemphigoid.
- For healthy controls: no diagnosis of the skin diseases studied.
Exclusion Criteria:
- Unable to provide informed consent or complete the study procedures.
- Systemic antibiotic treatment within 8 weeks before recruitment or during follow-up.
- Previous intestinal surgery.
- Inflammatory bowel disease, constipation, or diarrhea.
- Long-term alcohol use.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: CASE_CONTROL
- Tijdsperspectieven: PROSPECTIVE
Aantal groepen / cohorten
Cohorten en interventies
Groep / CohortGroep / Cohort |
|---|
|
Atopic Dermatitis
Adults aged 18 years or older with dermatologist-confirmed atopic dermatitis. Participants provide a stool sample and complete study assessments at baseline and about six months later. |
|
Psoriasis
Adults aged 18 years or older with dermatologist-confirmed psoriasis. Participants provide a stool sample and complete study assessments at baseline and about six months later. |
|
Hidradenitis Suppurativa
Adults aged 18 years or older with dermatologist-confirmed hidradenitis suppurativa. Participants provide a stool sample and complete study assessments at baseline and about six months later. |
|
Vitiligo
Adults aged 18 years or older with dermatologist-confirmed vitiligo. Participants provide a stool sample and complete study assessments at baseline and about six months later. |
|
Acne
Adults aged 18 years or older with dermatologist-confirmed acne. Participants provide a stool sample and complete study assessments at baseline and about six months later. |
|
Pemphigus
Adults aged 18 years or older with dermatologist-confirmed pemphigus. Participants provide a stool sample and complete study assessments at baseline and about six months later. |
|
Bullous Pemphigoid
Adults aged 18 years or older with dermatologist-confirmed bullous pemphigoid. Participants provide a stool sample and complete study assessments at baseline and about six months later. |
|
Healthy Controls
Adults aged 18 years or older who do not have the skin diseases studied. Participants provide one stool sample and complete study assessments at baseline. |
|
Alopecia Areata
dults aged 18 years or older with dermatologist-confirmed alopecia areata. Participants provide a stool sample and complete study assessments at baseline and about six months later. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Relative abundance of Bifidobacteriaceae in stool
Tijdsspanne: Baseline (T1)
|
Compare the relative abundance of the bacterial family Bifidobacteriaceae in stool between the combined group of adults with the eight skin diseases studied and healthy controls. Relative abundance is the number of sequences assigned to Bifidobacteriaceae divided by the total number of bacterial sequences. |
Baseline (T1)
|
Secundaire uitkomstmaten
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Relative abundance of Enterobacteriaceae in stool in the combined patient group
Tijdsspanne: Baseline (T1)
|
Compare the relative abundance of Enterobacteriaceae in stool between the combined group of adults with the eight skin diseases studied and healthy controls. |
Baseline (T1)
|
|
Relative abundance of Bifidobacteriaceae by skin-disease group
Tijdsspanne: Baseline (T1)
|
Compare stool Bifidobacteriaceae relative abundance between each disease group-atopic dermatitis, psoriasis, hidradenitis suppurativa, vitiligo, alopecia areata, acne, pemphigus, and bullous pemphigoid-and healthy controls. |
Baseline (T1)
|
|
Relative abundance of Enterobacteriaceae by skin-disease group
Tijdsspanne: Baseline (T1)
|
Compare stool Enterobacteriaceae relative abundance between each of the eight disease groups and healthy controls. |
Baseline (T1)
|
|
Change in stool Bifidobacteriaceae and Enterobacteriaceae over time
Tijdsspanne: Baseline (T1) to 6 months (T2)
|
Assess within-person changes in the relative abundance of Bifidobacteriaceae and Enterobacteriaceae between T1 and T2 in participants with skin disease. |
Baseline (T1) to 6 months (T2)
|
|
Associations between gut bacteria and disease-related measures
Tijdsspanne: Baseline (T1) and 6 months (T2)
|
Explore associations between Bifidobacteriaceae and Enterobacteriaceae relative abundance and disease activity scores, psychological impact scores, available routine laboratory markers, dietary intake, and anthropometric measures, as specified in the protocol. |
Baseline (T1) and 6 months (T2)
|
Medewerkers en onderzoekers
Sponsor
Sponsor
Medewerkers
Medewerkers
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Studie start
Primaire voltooiing (Geschat)
Primaire voltooiing
Studie voltooiing (Geschat)
Studie voltooiing
Studieregistratiedata
Eerst ingediend
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Eerst geplaatst
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update geplaatst
Laatste update ingediend die voldeed aan QC-criteria
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Genetische ziekten, aangeboren
- Auto-immuunziekten
- Ziekten van het immuunsysteem
- Infecties
- Overgevoeligheid, Onmiddellijk
- Overgevoeligheid
- Huidziekten, papulosquameus
- Huidziektes
- Alopecia
- Hypotrichose
- Haar Ziekten
- Bacteriële infecties
- Bacteriële infecties en mycosen
- Zweetklierziekten
- Huidziekten, bacterieel
- Huidziekten, besmettelijk
- Ettering
- Huidziekten, genetisch
- Huidziekten, Eczeem
- Acneïforme uitbarstingen
- Talgklierziekten
- Huidziekten, Vesiculobullair
- Dermatitis
- Hidradenitis
- Aangeboren, erfelijke en neonatale ziekten en afwijkingen
- Huid- en bindweefselaandoeningen
- Alopecia areata
- Hidradenitis suppurativa
- Psoriasis
- Dermatitis, atopisch
- Acné vulgaris
- Pemphigus
- Pemfigoïd, bulleus
Andere studie-ID-nummers
Andere studie-ID-nummers
- GUMIDIC
- 6708 (Andere identificatie: Comitato Etico Territoriale Lombardia 3)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .